Discovery of altered protein profiles in epithelial ovarian carcinogenesis by SELDI mass spectrometry

European Journal of Gynaecological Oncology

Volumn 29, Issue 3, 2008, Pages 233-238

  Luo, J ^a   Qian, J H ^a   Yu, J K ^b   Zheng, S ^b   Xie, X ^a   Lu, W G ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Epithelial ovarian cancer; Laser capture microdissection (LCM); Surface enhanced laser desorption ionization mass spectrometry (SELDI MS)

Indexed keywords

PROTEIN;

ARTICLE; CARCINOGENESIS; CELL TYPE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DESORPTION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZATION; LASER CAPTURE MICRODISSECTION; OVARY CANCER; OVARY TUMOR; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EPITHELIUM; FEMALE; HUMANS; MICRODISSECTION; OVARIAN NEOPLASMS; OVARY; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 44349099121     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C. et al.: "Cancer statistics, 2006". CA Cancer J. Clin., 2006, 56, 106.
2. Scott M., McCluggage W.G.: "Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data". Histol. Histopathol., 2006, 21, 81.
3. Craven R.A., Banks R.E.: "Laser capture microdissection and proteomics: possibilities and limitation". Proteomics, 2001, 1, 1200.
4. Yang C.Q., Chan K.Y., Ngan H.Y., Khoo U.S., Chiu P.M., Chan Q.K. et al.: "Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility". Carcinogenesis, 2006, 27, 1502.
5. Chiang J.W., Karlan B.Y., Cass L., Baldwin R.L.: "BRCA1 promoter methylation predicts adverse ovarian cancer prognosis". Gynecol. Oncol., 2006, 101, 403.
6. Tammela J., Odunsi K.: "Gene expression and prognostic significance in ovarian cancer". Minerva Ginecol., 2004, 56, 495.
7. Yoshizaki T., Enomoto T., Nakashima R., Ueda Y., Kanao H., Yoshino K. et al.: "Altered protein expression in endometrial carcinogenesis". Cancer Lett., 2005, 226, 101.
8. Zhukov T.A., Johanson R.A., Cantor A.B., Clark R.A., Tockman M.S.: "Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry". Lung Cancer, 2003, 40, 267.
9. Cheung P.K., Woolcock B., Adomat H., Sutcliffe M., Bainbridge T.C., Jones E.C. et al.: "Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis". Cancer Res., 2004, 64, 5929.
10. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M. et al.: "Use of proteomic patterns in serum to identify ovarian cancer". Lancet, 2002, 359, 572.
11. Zhang H., Kong B., Qu X., Jia L., Deng B., Yang Q.: "Biomarker discovery for ovarian cancer using SELDI-TOF-MS". Gynecol. Oncol., 2006, 102, 61.
12. Persson I.: "Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings". J. Steroid. Biochem. Mol. Biol., 2000, 74, 357.
13. Jones M.B., Krutzsch H., Shu H., Zhao Y., Liotta L.A., Kohn E.C. et al.: "Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer". Proteomics, 2002, 2, 76.
14. Petricoin E.F., Liotta L.A.: "SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer". Curr. Opin. Biotechnol., 2004, 15, 24.
15. Shih IeM., Kurman R.J.. "Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis". Am. J. Pathol., 2004, 164, 1511.
16. Ortiz B.H., Ailawadi M., Colitti C., Muto M.G., Deavers M., Silva E.G. et al.: "Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors". Cancer Res., 2001, 61, 7264.
17. Horiuchi A., Itoh K., Shimizu M., Nakai I., Yamazaki T., Kimura K. et al.: "Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach". Gynecol. Oncol., 2003, 88, 309.
18. Marquez R.T., Baggerly K.A., Patterson A.P., Liu J., Broaddus R., Frumovitz M. et al.: "Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon". Clin. Cancer Res., 2005, 11, 6116.